HOME >> BIOLOGY >> NEWS
Preventing obesity in children -- research highlights physical activity levels

A British study, involving 5,500 children and published in the latest issue of PLoS Medicine, used accurate methods to measure the fat mass of the children and the amount of physical activity they were taking. The researchers, based at the University of Bristol, concluded that low levels of activity, particularly moderate and vigorous activity, play an important role in the development of obesity.

While it would appear to be commonsense that anyone who is overweight or obese has been doing less physical activity than other people, body fat and energy expenditure are both hard to measure accurately. It has not therefore been clear which factor eating too much or doing too little is most responsible for the rising prevalence of obesity. The researchers employed advanced techniques an Actigraph accelerometer for activity and an X-ray emission absorptiometry scanner for fat mass. They considered that the top 10% of the children in terms of fat mass were obese.

The results show consistently that the lower the level of childrens activity the higher their fat mass. The effect was stronger in boys than in girls. The statistical association was found to be greater for moderate and vigorous activity than for total activity. While the researchers acknowledge their work to have some limitations, they urge that encouraging greater activity, especially moderate and vigorous activity, should be a key part of policies to address the obesity epidemic.

The research was part of the long-term Avon Longitudinal Study of Parents and Children, which is looking at many different aspects of health.


'"/>

Contact: Sarah Clark
press@plos.org
Public Library of Science
19-Mar-2007


Page: 1

Related biology news :

1. Preventing and treating lung cancer -- ESMO explores collaboration to fight cancer on all fronts
2. Preventing cancer without killing cells
3. Preventing graft-versus-host disease disease after bone marrow transplant -- without toxicity
4. Preventing ventilation induced lung injury depends on giving the right number of sighs
5. Preventing bacterial biofilms could help fight TB
6. Preventing fetal exposure to popular acne drug
7. Preventing a pandemic: Study suggests strategies for containing a flu outbreak
8. Size matters: Preventing large mammal extinction
9. Preventing muscle atrophy
10. Undesirable expatriates: Preventing the spread of invasive animals
11. Preventing SCD1 expression prevents obesity

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/8/2017)... 7, 2017 The biometrics market has ... confluence of organizations, desires to better authenticate or ... (password and challenge questions), biometrics is quickly working ... The market is driven by use cases, though ... and enterprise uses cases, with consumer-facing use cases ...
(Date:2/7/2017)... , February 7, 2017 ... Global Solutions Corporation [OTC: IDGS], ("Ipsidy" or the "Company") ... electronic transaction processing services, is pleased to announce the ... Company. Effective January 31, 2017, Philip ... of Directors, CEO and President.  An experienced payment industry ...
(Date:2/2/2017)... Feb. 2, 2017   TapImmune, Inc. ... company specializing in the development of innovative peptide ... of cancer and metastatic disease, announced today it ... manufacturing of a second clinical lot of TPIV ... receptor alpha. The manufactured vaccine product will be ...
Breaking Biology News(10 mins):
(Date:2/18/2017)... Research and Markets has announced the addition of the ... offering. ... report provides separate comprehensive analytics for the US, Japan ... Annual estimates and forecasts are provided for the period 2015 through ... Market data and analytics are derived from primary and secondary research. ...
(Date:2/17/2017)... 17, 2017  Protagonist Therapeutics, Inc. (NASDAQ: PTGX) ... oral peptide drug candidates, PTG-100 and PTG-200, at ... Crohn,s and Colitis Organization (ECCO).  The ECCO congress ... from February 15 – 18, 2017. ... on Protagonist drug candidates PTG-100 and PTG-200. PTG-100, ...
(Date:2/16/2017)... BEACH, Fla. , Feb. 16, 2017 /PRNewswire/ ... company revolutionizing the development of liquid biopsy tests ... has entered into an exclusive license agreement with ... distribute MDNA,s proprietary liquid biopsy test for prostate ... South Korea . This is the ...
(Date:2/16/2017)... 16, 2017 Patient Care ... innovative telemedicine application, new and leading edge therapies ... a boom worldwide. The healthcare sector as whole ... services and new therapies for companies such as ... Cellectar Biosciences, Inc. (NASDAQ: CLRB ), ...
Breaking Biology Technology:
Cached News: